Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

IMPORTANCE: The 2013/2014 American Society of Clinical Oncology and College of American Pathologists (ASCO-CAP) guidelines for HER2 testing by fluorescence in situ hybridization (FISH) designated an “equivocal” category (average HER2 copies per tumor cell ≥4-6 with HER2/CEP17 ratio <2.0) to be re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Press, Michael F., Seoane, Jose A., Curtis, Christina, Quinaux, Emmanuel, Guzman, Roberta, Sauter, Guido, Eiermann, Wolfgang, Mackey, John R., Robert, Nicholas, Pienkowski, Tadeusz, Crown, John, Martin, Miguel, Valero, Vicente, Bee, Valerie, Ma, Yanling, Villalobos, Ivonne, Slamon, Dennis J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2018
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439848/
https://ncbi.nlm.nih.gov/pubmed/30520947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.6012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados